HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
Not recruitingISRCTN56622673

Bipolarity adherence project

Research studyAges 18+United Kingdom
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
United Kingdom
Compensation
Payment and expense reimbursement have not been verified.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Mednet Consult Ltd
Sponsor type
Other organization
Study type
Other
Intervention type
Other / unclear
Study phase
Not clearly listed
Locations
United Kingdom
Age range
Over 18 Years
Official registry ID
ISRCTN56622673
Official title
Show the full official title

Bipolarity adherence project

Need help understanding this study?

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Loading the security check...

You can withdraw your consent at any time. Your data and your rights

Recruitment & locations

Not recruiting

United Kingdom

Checked Official study record (opens in a new tab)

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Mednet Consult Ltd.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as not recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.